Company: NIVFW
Filing Date: 2025-08-22
Form Type: DRS
Source: 0001213900-25-079717
Chunk: 53

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-22
Form: DRS
Chunk 53
---
 results may fluctuate significantly and may not fully reflect the underlying performance of NewGenIvf’s business.

NewGenIvf’s interim
and annual results of operations, including the levels of NewGenIvf’s revenues, expenses, net (loss)/income and other key metrics,
may vary significantly in the future due to a variety of factors, some of which are outside of NewGenIvf’s control, and period-to-period
comparisons of NewGenIvf’s operating results may not be meaningful, especially given NewGenIvf’s limited operating history.
Accordingly, the results for any one fiscal half year or any one fiscal year are not necessarily an indication of future performance.
Fluctuations in interim and/or annual financial results may adversely affect the price of NewGenIvf’s ordinary shares. Factors that
may cause fluctuations in NewGenIvf’s interim and annual financial results include:

| ● | NewGenIvf’s ability to attract new customers and maintain relationships with existing customers; |

| ● | changes in NewGenIvf’s products and services offered and introduction of new services and products; |

| ● | the amount and timing of operating expenses related to marketing and the maintenance and expansion of NewGenIvf’s business, operations and infrastructure; |

| ● | changes in the market price of Solana;                                                   |
| ● | changes in the market situation of the residential property in the United Arab Emirates; |
| ● | general economic, industry and market conditions; and                                    |

| ● | the timing of expenses related to the development or acquisition of technologies or businesses. |

<div align='center'>30</div>

If the estimates and assumptions NewGenIvf uses to determine the size of the target markets for its services are inaccurate, its future growth rate may be impacted and its business would be harmed.

Market opportunity estimates
and growth forecasts are subject to significant uncertainty and are based on assumptions and estimates that may not prove to be accurate.
Market opportunity estimates and growth forecasts included in this prospectus, including those NewGenIvf has generated itself, are subject
to significant uncertainty and are based on assumptions and estimates that may not prove to be accurate, including the risks described
in this prospectus. Even if the markets in which NewGenIvf competes achieve the forecasted growth, its business could fail to grow at
similar rates, if at all.

NewGenIvf’s estimates
of the market opportunity for its services are based on the assumption that the purpose-built, data-driven and disruptive